Key terms
About CTCX
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CTCX news
Apr 04
8:32am ET
Carmell Corporation announces $3M private placement
Mar 27
9:17am ET
Carmell Therapeutics closes Axolotl Biologix sale transaction
Mar 20
4:44pm ET
Carmell Therapeutics selling Axolotl Biologix subsidiary
Feb 26
8:35am ET
Carmell announces product development completed for G.L.E.E launch
No recent press releases are available for CTCX
CTCX Financials
Key terms
Ad Feedback
CTCX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CTCX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
